Results 231 to 240 of about 80,208 (340)

Faculty Opinions recommendation of A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor.

, 2006
Joseph Higgins
openalex   +2 more sources

Factor Analysis of Motor and Nonmotor Signs in Essential Tremor: Are These Signs All Part of the Same Underlying Pathogenic Process? [PDF]

, 2009
Elan D. Louis
openalex   +1 more source

Essential Tremor Suppression with a Novel Anti-Tremor Orthosis: A Randomized Crossover Trial. [PDF]

Mov Disord
Mugge W, Elstgeest LEM, van Ginkel M, Pol L, de Lange I, Pambakian N, Assis de Souza A, Helmich RC, Kamphuis DJ.   +8 more
europepmc   +1 more source

The research focus and frontiers in surgical treatment of essential tremor. [PDF]

Front Neurol
Zhang L, Cui S, Bi H, Chen Q, Kan M, Wang C, Pu Y, Cheng H, Huang B.   +8 more
europepmc   +1 more source

OBSERVATIONS ON ESSENTIAL TREMOR [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1962
openaire   +3 more sources

Benign Idiopathic Myoclonus: A New Clinical Entity?

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Myoclonus is a brief shock‐like, involuntary movement, which can be distinguished in physiologic, essential, epileptic, and symptomatic, according to its etiology. Physiologic myoclonus typically occurs in healthy people without disability or progression.
Giorgia Sciacca, A.M. Madelein van der Stouwe, Sterre van der Veen, Hendriekje Eggink, Martje E. van Egmond, Jan Willem J. Elting, Marina A.J. Tijssen   +6 more
wiley   +1 more source

Gait Velocity Alterations in Essential Tremor: a Meta-Analysis. [PDF]

Cerebellum
Harrison K, Peoples BM, Santamaria Guzman KG, Hunter EJ, Walker HC, Roper JA.   +5 more
europepmc   +1 more source

Clinical and Imaging Correlates of Medication Reduction in Globus Pallidus Stimulation for Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The magnitude and factors associated with levodopa equivalent daily dose (LEDD) reduction in deep brain stimulation (DBS) of the globus pallidus interna (GPi) for Parkinson's Disease (PD) remain unclear. Objective To investigate LEDD reduction in GPi DBS and its correlation with anatomical/clinical characteristics.
Daniel G. Di Luca, Carolina Ramirez‐Gomez, Brendan Santyr, Marco Fumagalli, Jürgen Germann, Suneil K. Kalia, Andres M. Lozano, Alfonso Fasano   +7 more
wiley   +1 more source

Clinical and Economic Correlates of Pharmacotherapy in Patients with Essential Tremor. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Pahwa R, Colletta K, Higgins D, Schroader BK, Davis BM, Hennum L, Louis ED.   +6 more
europepmc   +1 more source

Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early‐Onset and Familial Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Leucine‐rich repeat kinase 2 (LRRK2) p.L1795F variant was proposed as a genetic risk factor for Parkinson's disease (PD). However, its prevalence, phenotype, and origin remain unknown. Objective The aim was to evaluate the frequency and phenotype of p.L1795F in early‐onset PD (EOPD) and familial PD compared to healthy controls (HC ...
Miriam Ostrozovicova, Gertrud Tamas, Agsha Atputhavadivel, Petr Dusek, Milan Grofik, Vladimir Han, Petr Holly, Robert Jech, Katarina Kalinova, Peter Klivenyi, Norbert Kovacs, Kristina Kulcsarova, Egon Kurca, Alexandra Lackova, Hamin Lee, Patrick Lewis, Veronika Magocova, Maria Marekova, David Murphy, Ai Nagano, Jan Necpal, David Pinter, Miroslava Rabajdova, Evzen Ruzicka, Tereza Serranova, Katarzyna Smilowska, Krisztina Soos, Igor Straka, Tatiana Svorenova, Peter Valkovic, Katerina Zarubova, Zuzana Gdovinova, Henry Houlden, Mie Rizig, Matej Skorvanek, on behalf of the CEGEMOD consortium   +35 more
wiley   +1 more source